GPT Healthcare [GPTHEALTH] vs Dr. Agarwal's Eye [DRAGARWQ] Detailed Stock Comparison

GPT Healthcare

NSE
Loading...

Dr. Agarwal's Eye

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: GPT Healthcare wins in 10 metrics, Dr. Agarwal's Eye wins in 9 metrics, with 0 ties. GPT Healthcare appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricGPT HealthcareDr. Agarwal's EyeBetter
P/E Ratio (TTM)25.4940.35GPT Healthcare
Price-to-Book Ratio4.9011.14GPT Healthcare
Debt-to-Equity Ratio14.24158.94GPT Healthcare
PEG Ratio-1.141.81GPT Healthcare
EV/EBITDA16.1920.32GPT Healthcare
Profit Margin (TTM)11.44%13.96%Dr. Agarwal's Eye
Operating Margin (TTM)10.44%22.71%Dr. Agarwal's Eye
EBITDA Margin (TTM)10.44%22.71%Dr. Agarwal's Eye
Return on Equity20.14%26.07%Dr. Agarwal's Eye
Return on Assets (TTM)12.99%8.91%GPT Healthcare
Free Cash Flow (TTM)$174.71M$-83.80MGPT Healthcare
Dividend Yield1.57%0.11%GPT Healthcare
1-Year Return-16.71%4.92%Dr. Agarwal's Eye
Price-to-Sales Ratio (TTM)2.925.64GPT Healthcare
Enterprise Value$12.14B$26.43BDr. Agarwal's Eye
EV/Revenue Ratio2.926.38GPT Healthcare
Gross Profit Margin (TTM)61.63%77.64%Dr. Agarwal's Eye
Revenue per Share (TTM)$51$881Dr. Agarwal's Eye
Earnings per Share (Diluted)$5.81$123.07Dr. Agarwal's Eye
Beta (Stock Volatility)N/A-0.36N/A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

GPT Healthcare vs Dr. Agarwal's Eye Stock Performance Analysis

Loading Price Chart...

GPT Healthcare
Dr. Agarwal's Eye
GPT Healthcare Stock Overview | Dr. Agarwal's Eye Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
GPT Healthcare0.36%0.07%-2.76%0.09%-12.37%-19.15%
Dr. Agarwal's Eye-0.31%2.98%9.84%14.47%16.54%-23.53%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
GPT Healthcare-16.71%-22.75%-22.75%-22.75%-22.75%-22.75%
Dr. Agarwal's Eye4.92%358.10%1,895.43%3,647.65%6,296.19%14,656.04%

News Based Sentiment: GPT Healthcare vs Dr. Agarwal's Eye

GPT Healthcare

News based Sentiment: MIXED

September brought a mix of positive and negative developments for GPT Healthcare. While the company continues to engage with investors and make corporate governance changes, declining quarterly results and a high valuation premium create uncertainty. The overall narrative is one of cautious optimism, requiring close monitoring of future performance.

View GPT Healthcare News Sentiment Analysis

Dr. Agarwal's Eye

News based Sentiment: POSITIVE

September was a strong month for Dr. Agarwal's, marked by impressive financial results, a commitment to shareholder returns through a 35% dividend, and increasing institutional investor confidence. Long-term projections from Walletinvestor.com further reinforce a positive investment outlook, suggesting significant potential for future growth.

View Dr. Agarwal's Eye News Sentiment Analysis

Performance & Financial Health Analysis: GPT Healthcare vs Dr. Agarwal's Eye

MetricGPTHEALTHDRAGARWQ
Market Information
Market Cap i₹12.22B₹23.46B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i144,0011,476
90 Day Avg. Volume i201,7933,361
Last Close₹148.09₹4,950.65
52 Week Range₹126.10 - ₹192.00₹3,500.00 - ₹7,300.00
% from 52W High-22.87%-32.18%
All-Time High₹219.90 (Feb 26, 2024)₹7,300.00 (Dec 30, 2024)
% from All-Time High-32.66%-32.18%
Growth Metrics
Quarterly Revenue Growth0.10%0.17%
Quarterly Earnings Growth-0.23%0.22%
Financial Health
Profit Margin (TTM) i0.11%0.14%
Operating Margin (TTM) i0.10%0.23%
Return on Equity (TTM) i0.20%0.26%
Debt to Equity (MRQ) i14.24158.94
Cash & Liquidity
Book Value per Share (MRQ)₹30.21₹445.96
Cash per Share (MRQ)₹4.44₹52.76
Operating Cash Flow (TTM) i₹631.61M₹738.70M
Levered Free Cash Flow (TTM) i₹499.22M₹546.50M
Dividends
Last 12-Month Dividend Yield i1.57%0.11%
Last 12-Month Dividend i₹2.50₹5.00

Valuation & Enterprise Metrics Analysis: GPT Healthcare vs Dr. Agarwal's Eye

MetricGPTHEALTHDRAGARWQ
Price Ratios
P/E Ratio (TTM) i25.4940.35
Forward P/E i15.92510.88
PEG Ratio i-1.141.81
Price to Sales (TTM) i2.925.64
Price to Book (MRQ) i4.9011.14
Market Capitalization
Market Capitalization i₹12.22B₹23.46B
Enterprise Value i₹12.14B₹26.43B
Enterprise Value Metrics
Enterprise to Revenue i2.926.38
Enterprise to EBITDA i16.1920.32
Risk & Other Metrics
Beta iN/A-0.36
Book Value per Share (MRQ) i₹30.21₹445.96

Financial Statements Comparison: GPT Healthcare vs Dr. Agarwal's Eye

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)GPTHEALTHDRAGARWQ
Revenue/Sales i₹1.07B₹1.17B
Cost of Goods Sold i₹410.93M₹261.40M
Gross Profit i₹660.15M₹907.80M
Research & Development iN/AN/A
Operating Income (EBIT) i₹111.83M₹265.50M
EBITDA i₹189.28M₹379.30M
Pre-Tax Income i₹111.14M₹231.90M
Income Tax i₹34.32M₹59.30M
Net Income (Profit) i₹76.82M₹172.60M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)GPTHEALTHDRAGARWQ
Cash & Equivalents i₹16.59M₹111.60M
Total Current Assets i₹788.16M₹559.40M
Total Current Liabilities i₹742.43M₹869.80M
Long-Term Debt i₹227.25M₹3.06B
Total Shareholders Equity i₹2.48B₹2.10B
Retained Earnings i₹887.46M₹1.99B
Property, Plant & Equipment i₹2.27B₹1.37B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)GPTHEALTHDRAGARWQ
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricGPTHEALTHDRAGARWQ
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i144,0011,476
Average Daily Volume (90 Day) i201,7933,361
Shares Outstanding i82.05M4.70M
Float Shares i26.93M1.11M
% Held by Insiders i0.68%0.81%
% Held by Institutions i0.10%0.02%

Dividend Analysis & Yield Comparison: GPT Healthcare vs Dr. Agarwal's Eye

MetricGPTHEALTHDRAGARWQ
Last 12-Month Dividend i₹2.50₹5.00
Last 12-Month Dividend Yield i1.57%0.11%
3-Year Avg Annual Dividend i₹1.67₹4.50
3-Year Avg Dividend Yield i0.73%0.12%
3-Year Total Dividends i₹5.00₹13.50
Ex-Dividend DateJul 29, 2025Nov 08, 2024